Pharma: Chewing on growth pill has left a bad after-taste – MoneyControl.com

A contraction in its anti-infective business also hurt India operations. But the company is taking heart from the fact that even discounting its exclusive drug launches, its US and European operations have seen healthy growth. Ranbaxy is …

error: Content is protected !!